These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 27655518)
21. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Adrio JL; Olivares M; Xaus J; Zarzuelo A; Galvez J Int J Colorectal Dis; 2006 Dec; 21(8):737-46. PubMed ID: 16052308 [TBL] [Abstract][Full Text] [Related]
22. Physiological Characteristics of Liu Y; Li Y; Yu X; Yu L; Tian F; Zhao J; Zhang H; Zhai Q; Chen W J Microbiol Biotechnol; 2021 Jan; 31(1):92-103. PubMed ID: 32522964 [No Abstract] [Full Text] [Related]
23. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response. Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798 [TBL] [Abstract][Full Text] [Related]
24. Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects. Foligné B; Nutten S; Steidler L; Dennin V; Goudercourt D; Mercenier A; Pot B Dig Dis Sci; 2006 Feb; 51(2):390-400. PubMed ID: 16534687 [TBL] [Abstract][Full Text] [Related]
25. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Pavan S; Desreumaux P; Mercenier A Clin Diagn Lab Immunol; 2003 Jul; 10(4):696-701. PubMed ID: 12853407 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis. Kozik AJ; Nakatsu CH; Chun H; Jones-Hall YL PLoS One; 2019; 14(11):e0225079. PubMed ID: 31703107 [TBL] [Abstract][Full Text] [Related]
27. Bacteriocin biosynthesis contributes to the anti-inflammatory capacities of probiotic Lactobacillus plantarum. Yin X; Heeney D; Srisengfa Y; Golomb B; Griffey S; Marco M Benef Microbes; 2018 Feb; 9(2):333-344. PubMed ID: 29065706 [TBL] [Abstract][Full Text] [Related]
28. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice. Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120 [TBL] [Abstract][Full Text] [Related]
30. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice. Zhao Y; Zhang S; Jiang L; Jiang J; Liu H J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961 [TBL] [Abstract][Full Text] [Related]
31. The effect of selected Lactobacillus strains on dextran sulfate sodium-induced mouse colitis model. Hasannejad-Bibalan M; Mojtahedi A; Eshaghi M; Rohani M; Pourshafie MR; Talebi M Acta Microbiol Immunol Hung; 2020 Jun; 67(2):138-142. PubMed ID: 32554841 [TBL] [Abstract][Full Text] [Related]
32. Aronia melanocarpa fruit juice ameliorates the symptoms of inflammatory bowel disease in TNBS-induced colitis in rats. Valcheva-Kuzmanova S; Kuzmanov A; Kuzmanova V; Tzaneva M Food Chem Toxicol; 2018 Mar; 113():33-39. PubMed ID: 29331733 [TBL] [Abstract][Full Text] [Related]
33. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197 [TBL] [Abstract][Full Text] [Related]
35. Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis. Moeinian M; Ghasemi-Niri SF; Mozaffari S; Abdolghaffari AH; Baeeri M; Navaea-Nigjeh M; Abdollahi M World J Gastroenterol; 2014 Aug; 20(31):10876-85. PubMed ID: 25152589 [TBL] [Abstract][Full Text] [Related]
36. [Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model]. Wan YM; Zhu YQ; Xia B; Luo J Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):418-21. PubMed ID: 20646418 [TBL] [Abstract][Full Text] [Related]
37. Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis. Hrdý J; Couturier-Maillard A; Boutillier D; Lapadatescu C; Blanc P; Procházka J; Pot B; Ryffel B; Grangette C; Chamaillard M Sci Rep; 2022 Oct; 12(1):17591. PubMed ID: 36266398 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Peran L; Sierra S; Comalada M; Lara-Villoslada F; Bailón E; Nieto A; Concha A; Olivares M; Zarzuelo A; Xaus J; Gálvez J Br J Nutr; 2007 Jan; 97(1):96-103. PubMed ID: 17217564 [TBL] [Abstract][Full Text] [Related]
39. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. Zakostelska Z; Kverka M; Klimesova K; Rossmann P; Mrazek J; Kopecny J; Hornova M; Srutkova D; Hudcovic T; Ridl J; Tlaskalova-Hogenova H PLoS One; 2011; 6(11):e27961. PubMed ID: 22132181 [TBL] [Abstract][Full Text] [Related]
40. Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics. Celiberto LS; Pinto RA; Rossi EA; Vallance BA; Cavallini DCU Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]